Applications of Graphene and Graphene Oxide in Smart Drug/Gene Delivery: Is the World Still Flat?


Journal

International journal of nanomedicine
ISSN: 1178-2013
Titre abrégé: Int J Nanomedicine
Pays: New Zealand
ID NLM: 101263847

Informations de publication

Date de publication:
2020
Historique:
received: 03 06 2020
accepted: 12 09 2020
entrez: 7 12 2020
pubmed: 8 12 2020
medline: 31 12 2020
Statut: epublish

Résumé

Graphene, a wonder material, has made far-reaching developments in many different fields such as materials science, electronics, condensed physics, quantum physics, energy systems, etc. Since its discovery in 2004, extensive studies have been done for understanding its physical and chemical properties. Owing to its unique characteristics, it has rapidly became a potential candidate for nano-bio researchers to explore its usage in biomedical applications. In the last decade, remarkable efforts have been devoted to investigating the biomedical utilization of graphene and graphene-based materials, especially in smart drug and gene delivery as well as cancer therapy. Inspired by a great number of successful graphene-based materials integrations into the biomedical area, here we summarize the most recent developments made about graphene applications in biomedicine. In this paper, we review the up-to-date advances of graphene-based materials in drug delivery applications, specifically targeted drug/ gene delivery, delivery of antitumor drugs, controlled and stimuli-responsive drug release, photodynamic therapy applications and optical imaging and theranostics, as well as investigating the future trends and succeeding challenges in this topic to provide an outlook for future researches.

Identifiants

pubmed: 33281443
doi: 10.2147/IJN.S265876
pii: 265876
pmc: PMC7710865
doi:

Substances chimiques

Antineoplastic Agents 0
Drug Carriers 0
graphene oxide 0
Graphite 7782-42-5

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

9469-9496

Informations de copyright

© 2020 Hoseini-Ghahfarokhi et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

ACS Appl Mater Interfaces. 2017 Aug 30;9(34):29055-29062
pubmed: 28795557
Int J Mol Sci. 2018 Oct 17;19(10):
pubmed: 30336549
Nanomedicine (Lond). 2019 Aug;14(15):2011-2025
pubmed: 31355696
ACS Nano. 2010 Jun 22;4(6):3181-6
pubmed: 20481456
Nanotechnology. 2012 Sep 7;23(35):355101
pubmed: 22875697
Nanoscale. 2016 Feb 14;8(6):3530-8
pubmed: 26799192
Int J Biol Macromol. 2018 Jul 1;113:515-525
pubmed: 29496437
Mater Sci Eng C Mater Biol Appl. 2019 Jul;100:676-687
pubmed: 30948104
Nano Today. 2020 Oct;34:
pubmed: 32788923
Adv Drug Deliv Rev. 2003 Feb 24;55(3):329-47
pubmed: 12628320
Small. 2013 Jun 10;9(11):1989-97
pubmed: 23292791
Plasmid. 2016 Mar-May;84-85:51-60
pubmed: 27072918
Biomol Ther (Seoul). 2020 Jan 1;28(1):18-24
pubmed: 31597413
Circulation. 2005 Sep 20;112(12):1813-24
pubmed: 16172288
Adv Mater. 2012 Apr 10;24(14):1868-72
pubmed: 22378564
Small. 2011 Jun 6;7(11):1569-78
pubmed: 21538871
Sci Rep. 2019 Jan 23;9(1):416
pubmed: 30674914
Angew Chem Int Ed Engl. 2013 May 3;52(19):4986-97
pubmed: 23580235
Pharm Res. 2008 Jan;25(1):55-71
pubmed: 17551809
ACS Nano. 2015;9(4):3866-74
pubmed: 25849074
Anal Chim Acta. 2018 Oct 16;1027:109-120
pubmed: 29866260
Biotechnol Adv. 2018 Jul - Aug;36(4):968-985
pubmed: 29499341
Nano Res. 2008;1(3):203-212
pubmed: 20216934
Chem Biol Interact. 2018 Nov 1;295:97-108
pubmed: 30170108
ACS Biomater Sci Eng. 2018 Feb 12;4(2):514-531
pubmed: 33418741
ACS Nano. 2014 Aug 26;8(8):8050-62
pubmed: 24988275
Mol Pharm. 2013 Mar 4;10(3):857-66
pubmed: 23110457
J Phys Chem B. 2017 Jul 20;121(28):6822-6830
pubmed: 28650635
Nanoscale. 2011 Mar;3(3):1252-7
pubmed: 21270989
ACS Appl Mater Interfaces. 2015 Dec 30;7(51):28647-55
pubmed: 26641922
PLoS One. 2013;8(3):e60034
pubmed: 23527297
Adv Sci (Weinh). 2018 Jan 26;5(4):1700499
pubmed: 29721407
ACS Nano. 2017 Jul 25;11(7):6703-6716
pubmed: 28677399
ACS Appl Mater Interfaces. 2015 Feb 18;7(6):3512-23
pubmed: 25612470
ACS Appl Mater Interfaces. 2020 May 20;12(20):22507-22518
pubmed: 32255338
Chem Commun (Camb). 2019 Feb 7;55(13):1963-1966
pubmed: 30681672
ACS Nano. 2015 Sep 22;9(9):9199-209
pubmed: 26308265
J Am Chem Soc. 2011 May 4;133(17):6825-31
pubmed: 21476500
Int J Biol Macromol. 2019 Feb 15;123:389-397
pubmed: 30445077
Phys Chem Chem Phys. 2013 Apr 14;15(14):5176-85
pubmed: 23454895
Nanoscale Res Lett. 2014 Oct 27;9(1):587
pubmed: 25386104
Nat Rev Drug Discov. 2005 Jul;4(7):581-93
pubmed: 16052241
Sci Rep. 2018 Oct 3;8(1):14733
pubmed: 30283098
Mater Sci Eng C Mater Biol Appl. 2019 Dec;105:110094
pubmed: 31546441
Int J Pharm. 2016 May 17;504(1-2):110-6
pubmed: 26994523
ACS Appl Mater Interfaces. 2014 Jun 11;6(11):8173-83
pubmed: 24836601
Phys Rev Lett. 2010 Sep 17;105(12):127404
pubmed: 20867672
Small. 2013 Dec 9;9(23):4051-60
pubmed: 23839958
Int J Nanomedicine. 2019 Aug 30;14:6901-6915
pubmed: 31564860
ACS Nano. 2011 Sep 27;5(9):7000-9
pubmed: 21815655
Small. 2012 Mar 12;8(5):760-9
pubmed: 22228696
Nanotechnol Rev. 2018 Feb;7(1):95-122
pubmed: 29404233
J Phys Chem Lett. 2014 Jun 19;5(12):2150-4
pubmed: 26270507
Cell Cycle. 2020 May;19(9):961-989
pubmed: 32249682
Nanomedicine (Lond). 2019 Jan;14(1):93-126
pubmed: 30451076
Int J Nanomedicine. 2015 Oct 28;10:6709-24
pubmed: 26604747
Small. 2011 Feb 18;7(4):460-4
pubmed: 21360803
Biomaterials. 2009 Apr;30(12):2180-98
pubmed: 19200596
Sci Rep. 2016 Dec 12;6:38884
pubmed: 27941848
J Colloid Interface Sci. 2019 Feb 15;536:160-170
pubmed: 30366181
Br J Pharmacol. 2009 May;157(2):166-78
pubmed: 19459843
Acta Biomater. 2013 Dec;9(12):9243-57
pubmed: 23958782
J Control Release. 2014 Sep 10;189:80-9
pubmed: 24973719
J Food Drug Anal. 2014 Mar;22(1):3-17
pubmed: 24673900
Mater Sci Eng C Mater Biol Appl. 2019 Oct;103:109774
pubmed: 31349528
J Mater Chem B. 2014 Mar 14;2(10):1362-1370
pubmed: 32261451
Mater Sci Eng C Mater Biol Appl. 2020 May;110:110647
pubmed: 32204077
Trends Biotechnol. 2018 Nov;36(11):1145-1156
pubmed: 29954613
Nanomedicine. 2013 Oct;9(7):903-11
pubmed: 23352802
Biomaterials. 2014 Jun;35(18):4986-95
pubmed: 24656608
J Nanosci Nanotechnol. 2015 Mar;15(3):2052-9
pubmed: 26413620
ACS Appl Mater Interfaces. 2012 Nov;4(11):6317-23
pubmed: 23106794
Drug Discov Today. 2017 Sep;22(9):1318-1335
pubmed: 28428056
J Colloid Interface Sci. 2017 Jul 15;498:364-377
pubmed: 28343134
Small. 2010 Feb 22;6(4):537-44
pubmed: 20033930
J Control Release. 2014 Jan 10;173:75-88
pubmed: 24161530
Biomaterials. 2015 May;51:12-21
pubmed: 25770993
Biomaterials. 2016 Dec;109:12-22
pubmed: 27639528
J R Soc Interface. 2018 Feb;15(139):
pubmed: 29445040
Int J Pharm. 2017 Jun 30;526(1-2):391-399
pubmed: 28495579
Crit Rev Toxicol. 2009;39(7):613-26
pubmed: 19650720
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):90-94
pubmed: 30663418
Chem Sci. 2019 Aug 13;10(38):8880-8888
pubmed: 32874485
Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:558-565
pubmed: 28024622
Int J Biol Macromol. 2020 Aug 1;156:1396-1407
pubmed: 31760027
Adv Healthc Mater. 2015 Aug 5;4(11):1722-32
pubmed: 26033847
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Sep;8(5):696-716
pubmed: 26762467
Int J Pharm. 2018 Dec 1;552(1-2):301-311
pubmed: 30291961
Bioconjug Chem. 2015 Jan 21;26(1):128-36
pubmed: 25525819
Mater Sci Eng C Mater Biol Appl. 2016 Oct 1;67:478-485
pubmed: 27287145
Int J Nanomedicine. 2019 Dec 05;14:9603-9617
pubmed: 31824154
Expert Opin Drug Deliv. 2015 Jul;12(7):1089-105
pubmed: 25613837
Nat Mater. 2007 Mar;6(3):183-91
pubmed: 17330084
Adv Healthc Mater. 2014 Aug;3(8):1261-71
pubmed: 24652715
Colloids Surf B Biointerfaces. 2019 Apr 1;176:462-470
pubmed: 30682619
Chem Soc Rev. 2018 May 8;47(9):3059-3099
pubmed: 29513306
Biomaterials. 2013 Aug;34(26):6239-48
pubmed: 23706688
J Mater Chem B. 2018 Jul 28;6(28):4687-4696
pubmed: 32254413
Adv Drug Deliv Rev. 2016 Oct 1;105(Pt B):228-241
pubmed: 27233212
ACS Appl Mater Interfaces. 2018 May 9;10(18):15461-15466
pubmed: 29663807
Light Sci Appl. 2018 Nov 21;7:91
pubmed: 30479757
Sci Rep. 2016 Nov 15;6:37112
pubmed: 27845420
Nanoscale. 2013 Aug 7;5(15):6857-66
pubmed: 23770832
Chem Soc Rev. 2010 Jan;39(1):228-40
pubmed: 20023850
J Diabetes Sci Technol. 2008 Nov;2(6):1003-15
pubmed: 19885290
Adv Healthc Mater. 2016 Sep;5(18):2386-95
pubmed: 27385533
ACS Nano. 2013 Aug 27;7(8):6858-67
pubmed: 23829293
J Colloid Interface Sci. 2019 Jun 1;545:172-183
pubmed: 30878783
Colloids Surf B Biointerfaces. 2013 Jun 1;106:60-5
pubmed: 23434692
Colloids Surf B Biointerfaces. 2013 Nov 1;111:188-202
pubmed: 23810824
Chemistry. 2012 Apr 2;18(14):4208-15
pubmed: 22374621
Biomaterials. 2015 Oct;66:21-8
pubmed: 26188609
Biomaterials. 2013 Oct;34(31):7715-24
pubmed: 23859660
J Mater Chem B. 2013 Sep 21;1(35):4396-4405
pubmed: 24883188
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 Sep-Oct;1(5):511-29
pubmed: 20049814
Nanomedicine (Lond). 2017 Feb;12(4):357-385
pubmed: 28078952
ACS Appl Mater Interfaces. 2014 Oct 22;6(20):17526-33
pubmed: 25272041
ACS Omega. 2018 Nov 30;3(11):14620-14633
pubmed: 30555982
Int J Nanomedicine. 2020 Jul 30;15:5445-5458
pubmed: 32801699
Colloids Surf B Biointerfaces. 2018 Oct 1;170:393-400
pubmed: 29945051
Chem Soc Rev. 2017 Jul 31;46(15):4400-4416
pubmed: 28722038
Chem Asian J. 2019 May 2;14(9):1418-1423
pubmed: 30829452
Biomed Pharmacother. 2019 Feb;110:906-917
pubmed: 30572195
Int J Nanomedicine. 2018 Nov 14;13:7457-7472
pubmed: 30532533
Eur J Pharm Biopharm. 2016 Jul;104:235-50
pubmed: 27113141
Mater Sci Eng C Mater Biol Appl. 2018 Jun 1;87:50-59
pubmed: 29549949
Adv Drug Deliv Rev. 2010 Aug 30;62(11):1052-1063
pubmed: 20709124
J Am Chem Soc. 2008 Aug 20;130(33):10876-7
pubmed: 18661992
Sci Rep. 2016 Sep 06;6:32808
pubmed: 27597657
Trends Biotechnol. 2017 May;35(5):434-451
pubmed: 28108036
Adv Mater. 2015 Feb 11;27(6):1021-8
pubmed: 25504623
ACS Biomater Sci Eng. 2019 Mar 11;5(3):1384-1391
pubmed: 33405614
J Biophotonics. 2019 Jun;12(6):e201800367
pubmed: 30701677
Biomaterials. 2014 Jul;35(22):5847-61
pubmed: 24746963
J Mater Chem B. 2013 May 28;1(20):2658-2664
pubmed: 32260953
Nano Lett. 2010 Sep 8;10(9):3318-23
pubmed: 20684528
Int J Biol Macromol. 2018 Feb;107(Pt A):1184-1192
pubmed: 28951302
Nature. 2000 Sep 14;407(6801):249-57
pubmed: 11001068
Int J Pharm. 2013 Jun 25;450(1-2):208-17
pubmed: 23624082
Angiogenesis. 2014 Jan;17(1):37-50
pubmed: 23907365
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S297-S307
pubmed: 30183382
J Drug Target. 2018 Sep;26(8):633-642
pubmed: 29096554
J Biomater Appl. 2016 Mar;30(8):1230-41
pubmed: 26759390
Int J Nanomedicine. 2018 Sep 26;13:5799-5810
pubmed: 30310282
Nanoscale. 2015 Apr 14;7(14):6304-10
pubmed: 25782595
Biomaterials. 2012 Mar;33(7):2206-14
pubmed: 22169821
ACS Biomater Sci Eng. 2018 Jun 11;4(6):2143-2154
pubmed: 33435038
ACS Appl Mater Interfaces. 2015 Apr 22;7(15):8013-22
pubmed: 25821899
Colloids Surf B Biointerfaces. 2014 Oct 1;122:332-340
pubmed: 25064484
Sci Rep. 2018 Jan 12;8(1):586
pubmed: 29330486
Chem Commun (Camb). 2012 Oct 11;48(79):9912-4
pubmed: 22932979

Auteurs

Mojtaba Hoseini-Ghahfarokhi (M)

Nano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Soroush Mirkiani (S)

Neuroscience and Mental Health Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.

Naeimeh Mozaffari (N)

Research School of Electrical, Energy and Materials Engineering, The Australian National University, Canberra 2601, Australia.

Mohamad Amin Abdolahi Sadatlu (MA)

Department of Engineering and Science, Sharif University of Technology-International Campus, Kish, Iran.

Amir Ghasemi (A)

Department of Engineering, Durham University, Durham DH1 3LE, United Kingdom.
Advanced Nanobiotechnology and Nanomedicine Research Group (ANNRG), Iran University of Medical Sciences, Tehran, Iran.

Somayeh Abbaspour (S)

Department of Engineering, Durham University, Durham DH1 3LE, United Kingdom.

Mohsen Akbarian (M)

Pharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Fatemeh Farjadian (F)

Pharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

Mahdi Karimi (M)

Iran Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH